Cargando…

Di’ao Xinxuekang Capsule Improves the Anti-Atherosclerotic Effect of Atorvastatin by Downregulating the SREBP2/PCSK9 Signalling Pathway

Statins are the first choice for lowering low-density lipoprotein cholesterol (LDL-C) and preventing atherosclerotic cardiovascular disease (ASCVD). However, statins can also upregulate proprotein convertase subtilisin/kexin type 9 (PCSK9), which in turn might limits the cholesterol-lowering effect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Jiyi, Li, Wei, Liu, Honglin, Li, Xiaofen, Yuan, Chuqiao, Zou, Wenjun, Qu, Liping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096164/ https://www.ncbi.nlm.nih.gov/pubmed/35571088 http://dx.doi.org/10.3389/fphar.2022.857092

Ejemplares similares

Targeting Energy Protection as a Novel Strategy to Disclose Di’ao Xinxuekang against the Cardiotoxicity Caused by Doxorubicin
por: Wang, Tao, et al.
Publicado: (2023)

Di’ao Xinxuekang Capsule, a Chinese Medicinal Product, Decreases Serum Lipids Levels in High-Fat Diet-Fed ApoE(–/–) Mice by Downregulating PCSK9
por: Qu, Liping, et al.
Publicado: (2018)

Meta-Analysis of Randomized Controlled Trials on the Efficacy of Di'ao Xinxuekang Capsule and Isosorbide Dinitrate in Treating Angina Pectoris
por: Jia, Yongliang, et al.
Publicado: (2012)

Comparative Effectiveness of Di'ao Xin Xue Kang Capsule and Compound Danshen Tablet in Patients With Symptomatic Chronic Stable Angina
por: Yu, Yanan, et al.
Publicado: (2014)

Atorvastatin downregulates HSP22 expression in an atherosclerotic model in vitro and in vivo
por: Chen, Qi, et al.
Publicado: (2019)

Adoption of PCSK9 Inhibitors Among Patients With Atherosclerotic Disease
por: Dayoub, Elias J., et al.
Publicado: (2021)

Caffeine blocks SREBP2-induced hepatic PCSK9 expression to enhance LDLR-mediated cholesterol clearance
por: Lebeau, Paul F., et al.
Publicado: (2022)

An Anti-PCSK9 Antibody Reduces LDL-Cholesterol On Top Of A Statin And Suppresses Hepatocyte SREBP-Regulated Genes
por: Zhang, Liwen, et al.
Publicado: (2012)

Enhanced circulating PCSK9 concentration by berberine through SREBP-2 pathway in high fat diet-fed rats
por: Jia, Yan-Jun, et al.
Publicado: (2014)

Serum sdLDL-C and Cellular SREBP2-dependent Cholesterol Levels; is there a Challenge on Targeting PCSK9?
por: Soltanmohammadi, Elham, et al.
Publicado: (2016)

Development of Atorvastatin Calcium Biloaded Capsules for Oral Administration of Hypercholesterolemia
por: Senthilvel, Chitra Karthikeyini, et al.
Publicado: (2022)

Effect of atorvastatin therapy on oxidant-antioxidant status and atherosclerotic plaque formation
por: Sezer, Ebru Demirel, et al.
Publicado: (2011)

Add-On Effect of Probucol in Atherosclerotic, Cholesterol-Fed Rabbits Treated with Atorvastatin
por: Keyamura, Yuka, et al.
Publicado: (2014)

Estrogen Mediates an Atherosclerotic-Protective Action via Estrogen Receptor Alpha/SREBP-1 Signaling
por: Xie, Fei, et al.
Publicado: (2022)

Effects of Tanshinone IIA on the modulation of miR-33a and the SREBP-2/Pcsk9 signaling pathway in hyperlipidemic rats
por: JIA, LIANQUN, et al.
Publicado: (2016)

Retracted: Development of Atorvastatin Calcium Biloaded Capsules for Oral Administration of Hypercholesterolemia
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Atorvastatin Therapy Modulates Telomerase Activity in Patients Free of Atherosclerotic Cardiovascular Diseases
por: Strazhesko, Irina D., et al.
Publicado: (2016)

Experimental study of USPIO-enhanced MRI in the detection of atherosclerotic plaque and the intervention of atorvastatin
por: SHA, TING, et al.
Publicado: (2016)

Effect of PCSK9 on atherosclerotic cardiovascular diseases and its mechanisms: Focus on immune regulation
por: Ma, Minglu, et al.
Publicado: (2023)

Schisandra polysaccharide inhibits hepatic lipid accumulation by downregulating expression of SREBPs in NAFLD mice
por: Wang, Chun-Mei, et al.
Publicado: (2016)

Downregulation of SREBP inhibits tumor growth and initiation by altering cellular metabolism in colon cancer
por: Wen, Yang-An, et al.
Publicado: (2018)

Introduç{tilde}ao ao pensamento epistemológico /
por: Japiassu, Hilton
Publicado: (1986)

The Effect of PCSK9 Inhibition on the Stabilization of Atherosclerotic Plaque Determined by Biochemical and Diagnostic Imaging Methods
por: Basiak, Marcin, et al.
Publicado: (2023)

Effects of atorvastatin on serum lipids, serum inflammation and plaque morphology in patients with stable atherosclerotic plaques
por: GUO, SUXIA, et al.
Publicado: (2012)

Investigation of highly expressed PCSK9 in atherosclerotic plaques and ox-LDL-induced endothelial cell apoptosis
por: Li, Jiao, et al.
Publicado: (2017)

Trends in PCSK9 Inhibitor Prescriptions before and after the Price Reduction in Patients with Atherosclerotic Cardiovascular Disease
por: Smith, Alex, et al.
Publicado: (2021)

PCSK9 is minimally associated with HDL but impairs the anti-atherosclerotic HDL effects on endothelial cell activation
por: Dafnis, Ioannis, et al.
Publicado: (2022)

Educaç{tilde}ao e transiç{tilde}ao democrática /
Publicado: (1985)

AO Craniomaxillofacial Surgery (AO CMF): A World of Opportunities
por: Kadam, Dinesh
Publicado: (2020)

Lycium barbarum glycopeptide targets PER2 to inhibit lipogenesis in glioblastoma by downregulating SREBP1c
por: Yao, Jian, et al.
Publicado: (2023)

PCSK9 inhibitor and atorvastatin reduce cardiac impairment in ovariectomized prediabetic rats via improved mitochondrial function and Ca(2+) regulation
por: Amput, Patchareeya, et al.
Publicado: (2020)

Tongxinluo Capsule Combined with Atorvastatin for Coronary Heart Disease: A Systematic Review and Meta-Analysis
por: Liu, Qiao, et al.
Publicado: (2021)

The Complementary Effects of Atorvastatin and Exercise Treatment on the Composition and Stability of the Atherosclerotic Plaques in ApoE Knockout Mice
por: Moustardas, Petros, et al.
Publicado: (2014)

Effect of atorvastatin on the expression of gamma-glutamyl transferase in aortic atherosclerotic plaques of apolipoprotein E–knockout mice
por: Li, Gang, et al.
Publicado: (2014)

Correction to: Lycium barbarum glycopeptide targets PER2 to inhibit lipogenesis in glioblastoma by downregulating SREBP1c
por: Yao, Jian, et al.
Publicado: (2023)

Ao vivo no coliseu/
por: José Alonso

CARTA AO EDITOR
por: Amaral-Rosa, Marcelo Prado, et al.
Publicado: (2022)

Carta ao Editor
por: Peduzzi, Marina
Publicado: (2022)

Pioneer of burn medicine in China: Professor Li Ao and “Li Ao spirit”
por: Liao, Yaling, et al.
Publicado: (2020)

Real world effectiveness of PCSK-9 inhibitors combined with statins versus statins-based therapy among patients with very high risk of atherosclerotic cardiovascular disease in China (RWE-PCSK study)
por: LIU, Yu-Qi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5hdilia8nktk1j9bhi821ngk3c